Anti-IL5 therapies for chronic obstructive pulmonary disease

Donovan, T. and Crossingham, I. and Milan, S.J. and Wang, R. and Bradley, P. (2019) Anti-IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2019 (9). ISSN 1469-493X

[img] Text (Donovan_et_al-2019-Cochrane_Database_of_Systematic_Reviews)
Donovan_et_al_2019_Cochrane_Database_of_Systematic_Reviews.pdf - Published Version
Restricted to Repository staff only until 20 September 2020.
Available under License Creative Commons Attribution-NonCommercial.

Download (181kB)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

Item Type: Journal Article
Journal or Publication Title: Cochrane Database of Systematic Reviews
Additional Information: This is the peer reviewed version of the following article:Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti‐IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013432. DOI: 10.1002/14651858.CD013432 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013432/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords: /dk/atira/pure/subjectarea/asjc/2700
Subjects:
Departments: Faculty of Health and Medicine > Medicine
Faculty of Health and Medicine
ID Code: 137754
Deposited By: ep_importer_pure
Deposited On: 11 Oct 2019 08:35
Refereed?: Yes
Published?: Published
Last Modified: 13 Feb 2020 04:29
URI: https://eprints.lancs.ac.uk/id/eprint/137754

Actions (login required)

View Item View Item